These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8912529)

  • 1. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.
    Watson SA; Morris TM; Parsons SL; Steele RJ; Brown PD
    Br J Cancer; 1996 Nov; 74(9):1354-8. PubMed ID: 8912529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
    Watson SA; Morris TM; Robinson G; Crimmin MJ; Brown PD; Hardcastle JD
    Cancer Res; 1995 Aug; 55(16):3629-33. PubMed ID: 7627972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
    Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
    Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
    Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
    Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
    Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
    Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Batimastat. BB 94, collagenase inhibitors-1.
    Drugs R D; 1999 Feb; 1(2):139-41. PubMed ID: 10566008
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
    Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
    J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper.
    Escalante T; Franceschi A; Rucavado A; Gutiérrez JM
    Biochem Pharmacol; 2000 Jul; 60(2):269-74. PubMed ID: 10825472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice.
    Lee J; Weber M; Mejia S; Bone E; Watson P; Orr W
    Eur J Cancer; 2001 Jan; 37(1):106-13. PubMed ID: 11165137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
    Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
    Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig.
    de Smet BJ; de Kleijn D; Hanemaaijer R; Verheijen JH; Robertus L; van Der Helm YJ; Borst C; Post MJ
    Circulation; 2000 Jun; 101(25):2962-7. PubMed ID: 10869270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
    Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM
    Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer.
    Brown PD
    Ann N Y Acad Sci; 1994 Sep; 732():217-21. PubMed ID: 7978793
    [No Abstract]   [Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
    Brown PD
    Adv Enzyme Regul; 1995; 35():293-301. PubMed ID: 7572350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
    Rasmussen HS; McCann PP
    Pharmacol Ther; 1997; 75(1):69-75. PubMed ID: 9364582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites.
    Parsons SL; Watson SA; Steele RJ
    Eur J Surg Oncol; 1997 Dec; 23(6):526-31. PubMed ID: 9484924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.